Value of suppression with a gonadotropin-releasing hormone agonist prior to gonadotropin stimulation for in vitro fertilization

Fertility and Sterility
K DroeschZ Rosenwaks

Abstract

This study examined the use of gonadotropin-releasing hormone agonist (GnRHa) suppression before gonadotropin stimulation in 26 patients with failed prior in vitro fertilization (IVF) attempts and variable basal serum gonadotropin levels. Leuprolide, 1 mg subcutaneously per day, was administered from the midluteal phase of the cycle before IVF treatment. Concomitantly, stimulation was initiated on cycle day 3 with human menopausal gonadotropin (hMG) and follicle stimulating hormone (FSH). Based on their prior IVF attempts and serum gonadotropin levels on cycle day 3, 9 patients were high responders with elevated mean basal luteinizing hormone (LH)/FSH, 8 were low responders with elevated mean basal FSH/LH, 7 were intermediate responders with normal mean basal FSH/LH and a history of premature LH surge, and 2 had elevated (perimenopausal) mean FSH and LH. Leuprolide was discontinued on the day of human chorionic gonadotropin (hCG) administration. Prior IVF attempts in the same patients with the same protocol, but without GnRHa suppression, were used as controls. The mean number of ampules of hMG and FSH was significantly higher in leuprolide cycles than in controls. The mean day of hCG administration was also higher for leuproli...Continue Reading

Citations

Jun 1, 1992·Journal of Assisted Reproduction and Genetics·J CohenH E Malter
Feb 1, 1993·Journal of Assisted Reproduction and Genetics·Z Ben-Rafael, D Feldberg
Feb 1, 1993·Journal of Assisted Reproduction and Genetics·A EbrahimJ P Van der Merwe
Oct 1, 1996·Journal of Assisted Reproduction and Genetics·M M MahadevanD M Moutos
Nov 30, 2007·Journal of Assisted Reproduction and Genetics·Eric S Surrey
Nov 24, 2007·Journal of Assisted Reproduction and Genetics·D LoutradisA Antsaklis
Aug 24, 2012·Journal of Assisted Reproduction and Genetics·Leandros A LazarosIoannis A Georgiou
Aug 1, 1996·Talanta·F E Smith, E A Arsenault
Sep 26, 2000·Fertility and Sterility·J L FrattarelliR T Scott
Jan 13, 2001·Molecular and Cellular Endocrinology·S OehningerS Muasher
May 29, 2003·Molecular and Cellular Endocrinology·Shigeki TakekidaTakeshi Maruo
Nov 6, 2004·Journal of Assisted Reproduction and Genetics·John L Frattarelli, Catherine Lee Kodama
Oct 13, 2012·Best Practice & Research. Clinical Obstetrics & Gynaecology·Jack Yu Jen Huang, Zev Rosenwaks
Jul 29, 2005·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·János UrbancsekThomas Strowitzki
Oct 1, 1989·Journal of Steroid Biochemistry·G S JonesH C Liu
Jun 1, 1992·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·F MiróA Pellicer
Jan 1, 1991·Annals of the New York Academy of Sciences·K Gordon, G D Hodgen
Jan 1, 1991·Annals of the New York Academy of Sciences·M B DoyleA H Decherney
Jun 1, 1995·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·S SenözO Gökmen
Dec 1, 1994·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Z Ben-RafaelD Feldberg
Oct 6, 2011·Human Fertility : Journal of the British Fertility Society·Lata KambleRoy Homburg
Apr 21, 2011·Human Reproduction·A P FerrarettiUNKNOWN ESHRE working group on Poor Ovarian Response Definition
Jun 15, 2010·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Elissavet HatziIoannis Georgiou
Sep 1, 1990·Baillière's Clinical Obstetrics and Gynaecology·S Oehninger, G D Hodgen

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.